Antimigraine combination comprising sapindus and emblica extracts
CA 2409051 A1 · Owner: Lupin Limited · Inventors: Chikara, Jitendra; Gupta, Desh Bandhu
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The novel Synergistic pharmaceutical composition for prophylactic treatment of migraine comprising of aqueous extracts of Sapindus trifoliatusand Emblica officinalis in combination with pharmaceutically acceptable selective additives and process for manufacturing the same. The formulation of the invention is stable and effective in prophylactic treatment of migraine. The Synergistic composition is obtained in the form of aqueous nasal drops for effective prophylactic treatment of migraine which would be safe without any harmful side effect and in particular would avoid/reduce chances of damage/irritation to the nasal mucus membrane when administered nasally. The present invention …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 25, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 25, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 25, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.